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Abstract 
PCOC aims to assist services to improve the quality of the palliative care they provide through the 
analysis and benchmarking of patient outcomes. In this, the thirteenth PCOC report, data submitted for 
the January - June 2012 period are summarised and patient outcomes benchmarked to enable 
participating services to assess their performance and identify areas in which they may improve. 
This report is broken into four sections: 
Section 1 provides a summary of the data included in this report. 
Section 2 summarises each of the four outcome measures and presents national benchmarking results 
for a selection of these measures. 
Section 3 presents a more detailed analysis of the outcome measures and benchmarks. 
Section 4 provides descriptive analysis at each of the patient, episode and phase data levels. 
In each section the national figures reflect all palliative care services who submitted data for the January - 
June 2012 period. A full list of these services can be found at www.pcoc.org.au 
The four outcome measures included in this report were first introduced in the reporting period January to 
June 2009 (Report 7). There is strong sectoral support for national benchmarks and a consensus that 
such benchmarks can drive service innovation regardless of model of care. Benchmarking provides 
opportunities to understand the services that are provided, the outcomes patients experience and also to 
generate research opportunities focused on how to demonstrate variations in practice and outcomes. 
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About the Palliative Care Outcomes Collaboration (PCOC)  
 
PCOC is a unique national program that utilises standardised clinical assessment tools to measure and benchmark patient outcomes in palliative care. Participation in 
PCOC is voluntary and can assist palliative care service providers to improve practice and meet the Palliative Care Australia (PCA) Standards for Providing Quality 
Palliative Care for all Australians. This is achieved via the PCOC dataset; a multi-purpose framework designed to: 
 
• provide clinicians with an approach to systematically assess individual patient experiences 
• define a common clinical language to streamline communication between palliative care providers 
• facilitate the routine collection of national palliative care data to drive quality improvement through reporting and benchmarking  
The PCOC dataset includes the clinical assessment tools: Palliative Care Phase, Palliative Care Problem Severity Score (PCPSS), Symptom Assessment Scale (SAS), 
Australia-modified Karnofsky Performance Status Scale (AKPS) and Resource Utilisation Groups – Activities of Daily Living (RUG-ADL).  
 
PCOC has divided Australia into four zones for the purpose of engaging with palliative care service providers. Each zone is represented a chief investigator from one of 
the four collaborative centres. The four PCOC zones and their respective chief investigators are: 
 
 
Central Zone    Professor Kathy Eagar, Australian Health Services Research Institute, University of Wollongong 
North Zone        Professor Patsy Yates, Institute of Health and Biomedical Innovation, Queensland University of Technology 
South Zone        Professor David Currow, Department of Palliative and Supportive Services, Flinders University 
West Zone         Assistant Professor Claire Johnson, Cancer and Palliative Care Research and Evaluation Unit, University of WA 
 
Each zone is also represented by one or more quality improvement facilitators, whose role includes supporting services to participate in PCOC and facilitating ongoing 
service development and quality improvement. 
The National office is located within the Australian Health Services Research Institute at the University of Wollongong. If you would like more information about PCOC 
please visit our website www.pcoc.org.au or email us at pcoc@uow.edu.au or phone (02) 4221 4411. 
“PCOC is an excellent example of a national and voluntary programme using benchmarking to measure outcomes in palliative care” 
PRISMA (Reflecting the Positive DiveRsities of European PrIorities for ReSearch and Measurement in End-of-Life CAre) in their publication 
Outcome Measurement in Palliative Care – The Essentials 
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Introduction 
PCOC aims to assist services to improve the quality of the palliative care they provide through the analysis and benchmarking of patient outcomes. In this, the thirteenth 
PCOC report, data submitted for the January - June 2012 period are summarised and patient outcomes benchmarked to enable participating services to assess their 
performance and identify areas in which they may improve. 
 
This report is broken into four sections: 
 
Section 1 provides a summary of the data included in this report. 
Section 2 summarises each of the four outcome measures and presents national benchmarking results for a selection of these measures. 
Section 3 presents a more detailed analysis of the outcome measures and benchmarks. 
Section 4 provides descriptive analysis at each of the patient, episode and phase data levels. 
 
In each section the national figures reflect all palliative care services who submitted data for the January - June 2012 period. A full list of these services can be found at 
www.pcoc.org.au 
 
The four outcome measures included in this report were first introduced in the reporting period January to June 2009 (Report 7). There is strong sectoral support for 
national benchmarks and a consensus that such benchmarks can drive service innovation regardless of model of care. Benchmarking provides opportunities to 
understand the services that are provided, the outcomes patients experience and also to generate research opportunities focused on how to demonstrate variations in 
practice and outcomes. 
 
Note some tables throughout this report may be incomplete. Please use the following key when interpreting the tables: 
na The item is not applicable 
u The item was unavailable/unable to be calculated due to missing or invalid data. 
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Section 1 – Summary of data included in this report 
 
1.1 Data summary 
 
This report includes data from a total of 103 services. During the reporting period, data were provided for a total of 15,505 patients who between them had 19,157 
episodes of care and 41,947 palliative care phases. These total numbers are determined by a data scoping method. This method looks at the phase level data first and 
includes all phases that ended within the current reporting period. The associated episodes and patients are then determined (Section A contains a more detailed 
explanation of this process). Table 1 shows the number of patients, episodes and phases included in this report. 
 
A consequence of the data scoping method is that it is likely that not all phases related to a particular episode are included in this report. Hence, the average number of 
phases per episode calculation shown in Table 1 may be an underestimate (due to episodes that cross-over 2 or more reporting periods) as it only includes phases that 
ended within the current reporting period. 
 
 
Table 1  Number and percentage of patients, episodes and phases by setting 
Setting Inpatient Ambulatory & community Total 
Number of patients*    9,501    6,794 15,505 
Number of episodes   10,983    8,174 19,157 
Number of phases   27,814   14,133 41,947 
Percentage of patients*     61.3     43.8 100 
Percentage of episodes     57.3     42.7 100 
Percentage of phases     66.3     33.7 100 
Average number of  phases per episode**      2.4      1.7      2.1 
*     Patients seen in both settings are only counted once in the total column and hence numbers/percentages may not add to the total. 
**    Average number of phases per episode is only calculated for closed episodes, excludes bereavement phases and may also be an underestimate due to the data scoping methodology (see Section A).  
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1.2 Data Item Completion 
 
Overall, the quality of data submitted to PCOC is very good and, as shown in Tables 2, 3 and 4 below, the rate of data completion is very high. In reviewing these tables, it 
is important to note that in some cases some data items are not required to be completed. For example, place of death is only required for ambulatory and community 
patients who have died. Hence the complete column in the following tables only refers to the percentage of complete records where the data item was relevant.  
 
PCOC strongly encourages services to complete and submit the whole data set on every patient as non-completion may result in services being excluded from relevant 
benchmarking activities or erroneous conclusions being drawn. Low completion of data items may also distort percentages and graphs in some sections. 
 
 
  
Table 2  Item completion - patient level 
Data item % complete 
Date of birth    100.0 
Sex     99.9 
Indigenous status     96.1 
Country of birth     95.4 
Main language     93.4 
Primary diagnosis     96.8 
Note: This table is not split by setting to be consistent with 
the patient level analysis throughout this report. 
Table 3  Item completion by setting (per cent complete) - episode level 
Data item Inpatient Ambulatory & community Total 
Date of first contact/assessment     96.0     97.5     96.7 
Referral date     97.4     86.3     92.7 
Referral source     94.4     98.9     96.3 
Mode of episode start     99.7     98.9     99.4 
Accommodation at episode start     94.6     97.4     95.8 
Episode end date     99.3     99.9     99.6 
Level of support at episode start     81.3     83.1     82.1 
Mode of episode end     97.9     99.6     98.6 
Accommodation at episode end     84.7     77.9     83.0 
Level of support at episode end     98.2     89.5     96.1 
Place of death na     91.8     91.8 
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Table 4  Item completion by setting (per cent complete) - phase level 
Data item Sub-Category (where applicable) Inpatient Ambulatory & community Total 
RUG-ADL  
at phase start   
  
Bed mobility     96.8     97.1     96.9 
Toileting     96.9     96.9     96.9 
Transfers     96.8     96.6     96.7 
Eating     96.8     94.9     96.1 
PC Problem Severity  
at phase start   
  
Pain     79.5     84.2     81.2 
Other symptom     87.1     83.5     85.8 
Psychological/spiritual     98.2     84.1     93.3 
Family/carer     98.2     83.9     93.2 
Symptom Assessment 
Scale  
at phase start   
  
  
  
  
Insomnia     92.2     90.2     91.5 
Appetite problems     92.2     94.5     93.0 
Nausea     92.2     95.5     93.3 
Bowel problems     92.2     94.0     92.8 
Breathing problems     92.2     95.5     93.4 
Fatigue     92.2     95.9     93.5 
Pain     92.2     96.7     93.8 
Phase end reason  -     99.7     99.7     99.7 
Karnofsky at phase start  -     94.9     97.7     95.9 
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Section 2 – Benchmark summary  
2.1 Australia at a glance 
Table 5  Summary of outcome measures 1-3 by setting 
Outcome measure Description Benchmark Inpatient 
Ambulatory & 
community 
   National   
Score 
Benchmark  
Met? 
National 
Score 
Benchmark  
Met? 
1. Time from referral 
to first contact 
Benchmark 1: Patients contacted on the day of, or the day after referral 90% 90.3 Yes 51.1 No 
2. Time in unstable 
phase  
  
Benchmark 2.1: Patients in the unstable phase for less than 7 days – first phase of episode 85% 85.5 Yes 64.7 No 
Benchmark 2.2: Patients in the unstable phase for  less than 7 days - not first phase of episode 90% 90.2 Yes 70.7 No 
Benchmark 2.3: Median time patients are in the unstable phase 2 days 2 days Yes 3 days No 
3. Change in pain 
 
Benchmark 3.1: PCPSS: Patients with absent/mild pain at phase start, remaining absent/mild at phase end 90% 86.2 No  80.0 No 
Benchmark 3.2: PCPSS: Patients with moderate/severe pain at phase start, with absent/mild pain at phase end 60% 51.1 No  48.3 No 
Benchmark 3.3: SAS: Patients with absent/mild pain at phase start, remaining absent/mild at phase end 90% 84.5 No  80.9 No 
Benchmark 3.4: SAS: Patients with moderate/severe pain at phase start, with absent/mild pain at phase end 60% 47.9 No  45.1 No 
 
 
Table 6  Summary of outcome measure 4: Average improvement on the 2008 baseline national average (X-CAS) 
 
→ The benchmark for measure 4 is zero. 
 
 
For more information on the outcome 
measures and benchmarks, see Section 3 
and Appendix B 
 
 
Clinical Tool Description Average improvement on baseline Benchmark met? 
PCPSS 
  
  
  
Benchmark 4.1: Pain 0.16 Yes 
Benchmark 4.2: Other symptoms 0.27 Yes 
Benchmark 4.3: Family/carer 0.14 Yes 
Benchmark 4.4: Psychological/spiritual 0.15 Yes 
SAS 
  
  
  
Benchmark 4.5: Pain 0.28 Yes 
Benchmark 4.6: Nausea 0.20 Yes 
Benchmark 4.7: Breathing problems 0.35 Yes 
Benchmark 4.8: Bowel problems 0.26 Yes 
         
 Patient Outcomes in Palliative Care, Report 13 (January - June 2012) - National Report on Patient Outcomes in Palliative Care in Australia 6 
 
2.2 National benchmark profiles 
 
In this section, the national profiles for selected benchmarks are split by setting (inpatient and ambulatory & community) and presented graphically.  
The selected benchmarks included  are: 
• Benchmark 1 Patients contacted on the day of, or the day after referral 
• Benchmark 2.1 Patients in the unstable phase for less than 7 days – first phase of episode 
• Benchmark 2.2 Patients in the unstable phase for  less than 7 days - not first phase of episode 
• Benchmark 3.3 SAS: Patients with absent/mild pain at phase start, remaining absent/mild at phase end 
• Benchmark 3.4 SAS: Patients with moderate/severe pain at phase start, with absent/mild pain at phase end 
 
In each of the following graphs, the shaded region describes the national profile for that outcome measure and the red line on the graph indicates the benchmark for 
that measure. 
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Outcome measure 1 – Time from referral to first contact 
Benchmark 1 
Figure 1  Percentage of patients contacted on the day of, or the day after referral – inpatient setting 
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Figure 2  Percentage of patients contacted on the day of, or the day after referral – ambulatory & community settings 
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Outcome measure 2 – Time in unstable phase 
Benchmark 2.1 
Figure 3  Percentage of patients in the unstable phase for less than 7 days - 1st phase of episode – inpatient setting 
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Figure 4  Percentage of patients in the unstable phase for less than 7 days - 1st phase of episode – ambulatory & community settings 
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Benchmark 2.2 
Figure 5  Percentage of patients in the unstable phase for less than 7 days - not 1st phase of episode – inpatient setting 
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Figure 6  Percentage of patients in the unstable phase for less than 7 days - not 1st phase of episode – ambulatory & community settings 
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Outcome measure 3 – Change in pain (SAS pain) 
Benchmark 3.3 
Figure 7  Percentage of patients with absent/mild pain at phase start, remaining absent/mild at phase end – inpatient setting 
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Figure 8  Percentage of patients with absent/mild pain at phase start, remaining absent/mild at phase end – ambulatory & community settings 
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Benchmark 3.4 
Figure 9  Percentage of patients with moderate/severe pain at phase start, with absent/mild pain at phase end – inpatient setting 
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Figure 10  Percentage of patients with moderate/severe pain at phase start, with absent/mild pain at phase end – ambulatory & community settings 
 
  
         
 Patient Outcomes in Palliative Care, Report 13 (January - June 2012) - National Report on Patient Outcomes in Palliative Care in Australia 17 
Section 3 – Outcome measures in detail 
 
3.1 Outcome measure 1 – Time from referral to first contact 
 
Time from referral to first contact reports responsiveness of palliative care services to patient needs. This benchmark was set after consultation with participants at the 
PCOC national benchmarking workshops in 2008. Participants acknowledged that, whilst there is wide variation in the delivery of palliative care across the country, 
access to palliative care should be measured based on patient need rather than service availability. As a result, services operating 5 days a week (Monday-Friday) are not 
distinguished from services operating 7 days a week (all services are being benchmarked together). 
Benchmark 1: This measure relates to the time taken for patients to be contacted and clinically assessed, once the palliative care team has received the 
patient’s referral. To meet the benchmark for this measure, at least 90% of patients must be contacted on the same day of, or the following day 
of receipt of referral. 
 
The time from referral to first contact is calculated as the time from the date of referral received to either the date of first contact (if provided) or the episode start date.  
 
Table 7  Time from referral to first contact by setting 
Time (in days) 
Inpatient Ambulatory & community 
N % N % 
Same day or following day    9,657     90.3    3,605     51.1 
2-7 days      845      7.9    2,259     32.0 
8-14 days       97      0.9      716     10.2 
Greater than 14 days      101      0.9      471      6.7 
Average      1.3 na      3.0 na 
Median        1 na        1 na 
Note: Episodes where referral date was not recorded are excluded from the table. In addition, all records where time from referral to first contact was greater than 7 days were considered to be atypical and 
were assumed to equal 7 days for the purpose of calculating the average and median time. 
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Figure 11  Trends in time from referral to first contact by setting 
 
 
 
Inpatient setting  Ambulatory & community settings  
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3.2 Outcome measure 2 – Time in unstable phase 
 
The unstable phase type, by nature of its definition, alerts clinical staff to the need for urgent changes to the patient’s plan of care or that emergency intervention is 
required. Those patients assessed to be in the unstable phase require intense review for a short period of time. An unstable phase is triggered if: 
• a patient experiences a new, unanticipated problem, and/or 
• a patient experiences a rapid increase in the severity of an existing problem, and/or 
• a patient’s family/carers experience a sudden change in circumstances that adversely impacts the patients care 
Unstable phases are ended in one of two ways: 
• A new plan of care has been put in place, has been reviewed and does not require any additional changes. This does not necessarily mean that the 
symptom/crisis has been fully resolved. However, the clinical team will have a clear diagnosis and a plan for the patient’s care. In this situation, the patient will 
move to either the stable or deteriorating phase 
• The patient is likely to die within a matter of days. In this situation, the patient will be moved into the terminal phase 
There are three benchmarks relating to the time in unstable phase measure: 
Benchmark 2.1: This benchmark relates to unstable phases that are the first phase in a patient’s episode of care (for example, a patient is admitted to an 
inpatient palliative care unit and is immediately assessed as being in the unstable phase). To meet this benchmark, at least 85% of these unstable 
phases must last for less than 7 days. 
Benchmark 2.2: This benchmark relates to unstable phases that are not the first phase in a patient’s episode of care (for example, a patient’s condition changes 
during an episode of care, and the patient’s phase type is changed to unstable). To meet this benchmark, at least 90% of these unstable phases 
must last for less than 7 days. 
Benchmark 2.3: This benchmark relates to all unstable phases, regardless of where they occur in a patient’s episode of care. To meet this benchmark, the median 
length of all unstable phases must be 2 days or less. 
 
Table 8 presents descriptive data for these three benchmarks. 
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Table 8  Time in unstable phase by setting and occurrence in episode 
Setting 
Occurrence of unstable 
phase 
Number of unstable 
phases 
Percent unstable for < 7 
days 
Median days in 
unstable phase 
Inpatient 
First phase of episode     5,046     85.5  2 
Not first phase of episode 2,275     90.2  2 
Total unstable phases 7,321     86.9  2 
Ambulatory &  
community 
First phase of episode       846     64.7  4 
Not first phase of episode 1,141     70.7  2 
Total unstable phases  1,987     68.1  3 
 
 
Interpretation hint:  
5,046 patients commenced their inpatient episode of care in the unstable phase. Of these unstable phases, 85.5% remained for 
less than 7 days.  
 
846 patients commenced their ambulatory/community episode of care in the unstable phase. Of these unstable phases, 64.7% 
remained for less than 7 days. 
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3.3 Outcome measure 3 – Change in pain 
 
Pain management is acknowledged as a core business of palliative care services. The Palliative Care Problem Severity Score (PCPSS) and Symptom Assessment Scale (SAS) 
provide two different perspectives of pain: the SAS is patient rated, while the PCPSS is clinician rated. There are two benchmarks related to each tool: one relating to the 
management of pain for patients with absent or mild pain, and the other relating to the management of pain for patients with moderate or severe pain. The PCPSS is 
rated from 0 to 3 (absent, mild, moderate and severe) whereas the SAS is rated on a scale of 0 to 10 (0 = absent and 10 = the worst possible). For the analysis in this 
report SAS scores have been grouped as 1-3 mild, 4-7 moderate and 8-10 severe. 
 
Phase records must have valid start and end scores for the PCPSS and/or SAS clinical assessment tools to be included in the benchmarks. 
 
Benchmark 3.1: This benchmark relates to patients who have absent or mild pain at the start of their phase of palliative care, as rated via the PCPSS clinical tool. 
To meet this benchmark, 90% of these phases must end with the patient still experiencing only absent or mild pain. Table 9 shows trends in this 
benchmark over the last four reports. 
 
Table 9  Trends in Benchmark 3.1: Patients with absent/mild pain at phase start, remaining absent/mild at phase end (PCPSS) by setting 
Setting  Report 10 Report 11 Report 12 Report 13 
Inpatient 
Number    3,969    5,153    5,577    7,362     
%     79.0     82.1     81.6     86.2     
Ambulatory & community Number    2,415    2,176    2,339    3,276     
%     74.9     75.1     77.5     80.0 
 
Benchmark 3.2: This benchmark relates to patients who have moderate or severe pain at the start of their phase of palliative care, as rated via the PCPSS clinical 
tool. To meet this benchmark, 60% of these phases must end with the patient’s pain reduced to being absent or mild. Table 10 shows trends in 
this benchmark over the last four reports. 
 
Table 10  Trends in Benchmark 3.2:  Patients with moderate/severe pain at phase start, with absent/mild pain at phase end (PCPSS) by setting 
Setting  Report 10 Report 11 Report 12 Report 13 
Inpatient 
Number    1,655    1,858    1,986    2,220     
%     46.6     48.0     53.6     51.1     
Ambulatory & community Number      806      646      697      742     
%     57.5     57.3     55.4     48.3 
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Benchmark 3.3: This benchmark relates to patients who have absent or mild pain at the start of their phase of palliative care, as rated via the SAS clinical tool. To 
meet this benchmark, 90% of these phases must end with the patient still experiencing only absent or mild pain. Table 11 shows trends in this 
benchmark over the last four reports. 
 
Table 11  Trends in Benchmark 3.3: Patients with absent/mild pain at phase start, remaining absent/mild at phase end (SAS) by setting 
Setting  Report 10 Report 11 Report 12 Report 13 
Inpatient 
Number    4,672    5,902    6,476    8,179     
%     78.8     81.8     82.5     84.5     
Ambulatory & community Number    2,825    2,566    2,816    4,112     
%     76.4     76.8     78.1     80.9 
 
 
Benchmark 3.4: This benchmark relates to patients who have moderate or severe pain at the start of their phase of palliative care, as rated via the SAS clinical 
tool. To meet this benchmark, 60% of these phases must end with the patient’s pain reduced to being absent or mild. Table 12 shows trends in 
this benchmark over the last four reports. 
 
Table 12  Trends in Benchmark 3.4: Patients with moderate/severe pain at phase start, with absent/mild pain at phase end (SAS) by setting 
Setting  Report 10 Report 11 Report 12 Report 13 
Inpatient 
Number    1,912    2,159    2,216    2,789     
%     45.7     46.4     49.6     47.9     
Ambulatory & community Number      846      708      787      911     
%     55.3     57.0     56.2     45.1 
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Figure 12  Trends in outcome measure 3 
 
Benchmark 3.1: Absent/mild pain at both start and end of phase (using PCPSS) Benchmark 3.2: Mod/severe pain at start with absent/mild pain at end (using PCPSS) 
  
Benchmark 3.3: Absent/mild pain at both start and end of phase (using SAS)  Benchmark 3.4: Mod/severe pain at start with absent/mild pain at end (using SAS) 
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3.4 Outcome measure 4 – Change in symptoms relative to the baseline national average (X-CAS) 
 
Measure 4 includes a suite of case-mix adjusted scores used to compare the change in symptoms for similar patients i.e. patients in the same phase who started with the 
same level of symptom. Eight symptoms are included in this report: 
 
PCPSS SAS 
4.1 Pain  4.5 Pain 
4.2 Other symptoms 4.6 Nausea 
4.3 Family/carer 4.7 Breathing problems 
4.4 Psychological/spiritual 4.8 Bowel problems 
 
The suite of benchmarks included in Measure 4 are generally referred to as X-CAS – CAS standing for Case-mix Adjusted Score, and the X to represent that multiple 
symptoms are included. 
 
 
 
Interpretation hint:  
 
The X-CAS benchmarks are calculated relative to a baseline reference period (currently July-December 2008). As a result: 
 
If X-CAS is greater than 0 then on average, patients’ change in symptom was better than similar patients in the baseline reference period.  
If X-CAS is equal to 0 then on average, patients’ change in symptom was about the same as similar patients in the baseline reference period. 
If X-CAS is less than 0 then on average, patients’ change in symptom was worse than similar patients in the baseline reference period. 
 
As the X-CAS measures look at change in symptom, they are only able to be calculated on phases which ended in phase change or discharge (as the phase end scores are 
required to determine the change). Bereavement phases are excluded from the analysis.  
 
A more technical explanation of X-CAS is included in Appendix B. 
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Figure 13  Trends in outcome measure 4 – Palliative Care Problem Severity Score (PCPSS) 
 
 
  Benchmark 4.1:  Pain  Benchmark 4.2:  Other symptoms 
  
 Benchmark 4.3:  Family/carer   Benchmark 4.4:  Psychological/spiritual 
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Figure 14  Trends in outcome measure 4 – Symptom Assessment Scale (SAS) 
 
 
 Benchmark 4.5:  Pain  Benchmark 4.6:  Nausea 
  
  
 Benchmark 4.7:  Breathing problems 
  
 Benchmark 4.8:  Bowel problems 
  
  
         
 Patient Outcomes in Palliative Care, Report 13 (January - June 2012) - National Report on Patient Outcomes in Palliative Care in Australia 27 
Section 4 - Descriptive analysis 
 
There are three levels of PCOC data items – patient, episode and phase. 
 
The broad detail is found at the patient level, where the data items look at patient demographics. 
 
At the episode level, the items focus on characterising each setting of palliative care. They also describe the reasons behind why and how palliative care episodes 
start/end, the level of support patients receive both before and after an episode and (where applicable) the setting in which the patient died.  
 
The clinical focus of PCOC is at the phase level. The items at this level describe the patient’s stage of illness, functional impairment as well as their levels of pain and 
other symptom distress. The items at the phase level are used to quantify patient outcomes, and are the focus of the PCOC benchmarks in the previous sections. 
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4.1 Profile of palliative care patients 
 
The information collected on each patient includes Indigenous status, sex, main language spoken at home and country of birth. Table 13 shows the Indigenous status for 
all patients nationally. Non-disclosure of Indigenous status can result in cultural issues not being identified. A number of programs exist that can assist services to 
encourage Indigenous persons to identify.  
Table 13  Indigenous status  
Indigenous status N % 
Aboriginal but not Torres Strait Islander origin      137      0.9 
Torres Strait Islander but not Aboriginal origin       15      0.1 
Both Aboriginal and Torres Strait Islander origin       15      0.1 
Neither Aboriginal nor Torres Strait Islander origin   14,732     95.0 
Not stated/inadequately described      606      3.9 
Total   15,505    100.0 
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The following two tables show the main language spoken at home and the country of birth respectively for all patients nationally. To allow for comparison with the 
broader Australian community the list of languages in Table 14 is in descending order of the most frequently spoken languages according to the 2006 Census (e.g. Greek 
was the third most frequently spoken language in the 2006 Census). The same approach has been taken with Table 15 (e.g. Italy was the third highest country of birth in 
the 2006 Census). All other languages and countries have been grouped together to form the categories All other languages and All other countries respectively.  
 
  
Table 14  Main language spoken at home  
Main language spoken at home N % 
English   13,181     85.0 
Italian      268      1.7 
Greek      194      1.3 
Cantonese       80      0.5 
Arabic (including Lebanese)       59      0.4 
Mandarin       63      0.4 
Vietnamese       69      0.4 
Spanish       45      0.3 
German       15      0.1 
Hindi        6      0.0 
Macedonian       54      0.3 
Croatian       52      0.3 
Korean       10      0.1 
Turkish       15      0.1 
Polish       45      0.3 
All other languages      322      2.1 
Not stated/inadequately described    1,027      6.6 
Total   15,505    100.0 
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Table 15  Country of birth  
Country of birth N % 
Australia    9,768     63.0 
England    1,124      7.2 
Italy      249      1.6 
Scotland      145      0.9 
New Zealand      572      3.7 
Greece       95      0.6 
Netherlands       92      0.6 
Germany      200      1.3 
China       38      0.2 
Poland      327      2.1 
Malta      205      1.3 
Croatia       60      0.4 
Ireland       40      0.3 
India      168      1.1 
Vietnam       68      0.4 
All other countries    1,635     10.5 
Not stated/inadequately described      719      4.6 
Total   15,505    100.0 
 
 
Table 16 on the following page presents a breakdown of malignant and non-malignant diagnosis.  
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Table 16  Primary diagnosis 
Diagnosis category Primary diagnosis N % of category % of total 
Malignant                         Bone and soft tissue                238 1.9 1.5 
Breast                              958 7.8 6.2 
CNS                                 194 1.6 1.3 
Colorectal                          1,370 11.2 8.8 
Gynaecological                      585 4.8 3.8 
Haematological                      623 5.1 4.0 
Head and neck                       671 5.5 4.3 
Lung                                2,470 20.1 15.9 
Pancreas                            767 6.2 4.9 
Prostate                            794 6.5 5.1 
Skin                                432 3.5 2.8 
Other GIT                           995 8.1 6.4 
Other urological                    442 3.6 2.9 
Other malignancy                    724 5.9 4.7 
Unknown primary                     338 2.8 2.2 
Malignant - not further defined     677 5.5 4.4 
All malignant 12,278 100.0 79.2 
Non-malignant                     Cardiovascular                      555 20.3 3.6 
HIV/AIDS                            4 0.1 0.0 
Kidney failure                      290 10.6 1.9 
Neurological disease                558 20.4 3.6 
Respiratory failure                 439 16.1 2.8 
Other non-malignancy                804 29.4 5.2 
Non-malignant - not further defined 82 3.0 0.5 
All non-malignant 2,732 100.0 17.6 
Not Stated - 495 100.0 3.2 
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4.2 Profile of palliative care episodes 
 
An episode of care is a period of contact between a patient and a palliative care service that is provided by one palliative care service and occurs in one setting – for the 
purposes of this report, either as an inpatient or ambulatory and community patient.  
 
An episode of palliative care begins on the day the patient is assessed face to face by the palliative care provider and there is agreement between the patient and the 
service. 
 
An episode of palliative care ends when: 
 
• the principal clinical intent of the care changes and the patient is no longer receiving palliative care 
• the patient is formally separated from the hospital/hospice/community or, 
• the patient dies 
 
Table 17 below presents the number and percentage of episodes by age group and gender. Age has been calculated as at the beginning of each episode. 
 
Table 17  Age group by gender 
Age group Male % Female % 
< 15       40      0.4       44      0.5 
15-24       31      0.3       28      0.3 
25-34       48      0.5       68      0.8 
35-44      245      2.4      272      3.1 
45-54      630      6.1      800      9.0 
55-64    1,822     17.8    1,645     18.5 
65-74    2,761     26.9    1,995     22.5 
75-84    3,160     30.8    2,335     26.3 
85+    1,517     14.8    1,699     19.1 
Not stated/inadequately described        1      0.0        0      0.0 
Total   10,255    100.0    8,886    100.0 
Note: Records where gender was not stated or inadequately described are excluded from the table. 
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Referral source refers to the service or organisation from which the patient was referred for each episode of care. Table 18 presents referral source by episode type. 
Review of referral source can identify opportunities to connect with referral sources that are currently lower than the national referral profile (e.g. a community service 
with few GP referrals may want to re-address referral or triage practices and look to working more collaboratively). 
 
Table 18  Referral source by setting 
Referral source 
Inpatient Ambulatory & community 
N % N % 
Public hospital - other than inpatient palliative care unit    5,063     46.1    3,531     43.2 
Self, carer(s), family or friends      323      2.9      235      2.9 
Private hospital - other than inpatient palliative care unit      714      6.5    1,349     16.5 
Public palliative care inpatient unit/hospice      220      2.0      322      3.9 
Private palliative care inpatient unit/hospice       83      0.8      114      1.4 
General medical practitioner      537      4.9    1,166     14.3 
Specialist medical practitioner      567      5.2      588      7.2 
Community-based palliative care agency    2,225     20.3      151      1.8 
Community-based service      461      4.2      193      2.4 
Residential aged care facility       75      0.7      265      3.2 
Other       99      0.9      169      2.1 
Not stated/inadequately described      616      5.6       91      1.1 
Total   10,983    100.0    8,174    100.0 
 
Table 19  Place of death – ambulatory & community setting  
Place of death N % 
Private residence    1,237 53.1 
Residential aged care setting      449 19.3 
Other location*      452 19.4 
Not stated/inadequately described      190 8.2 
Total    2,328 100.0 
* Includes patients who have died in a hospital setting without the episode of non-admitted palliative care being ended. Patients whose community  
  episode has  ended when admitted to hospital are excluded from this table.  
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Table 20 gives a summary of the length of episode and Table 21 details the length of episode by setting. The length of episode is calculated as the number of days 
between the episode start date and the episode end date. Bereavement phases are excluded from the calculation and episodes that remain open at the end of the 
reporting period (and hence do not have an episode end date) are also excluded. 
 
Table 20  Length of episode summary by setting 
Length of episode Inpatient Ambulatory & community 
Average length of episode     11.9     34.7 
Median length of episode      7.0     22.0 
Note: Records where length of episode was greater than 180 days were considered to be atypical and are excluded from the average calculations. 
 
 
Table 21  Length of episode by setting 
Length of episode 
Inpatient Ambulatory & community 
N % N % 
Same day      389 3.7           713 9.4 
1-2 days    2,047 19.4          529 7.0 
3-4 days    1,497 14.2          418 5.5 
5-7 days    1,730 16.4          570 7.5 
8-14 days    2,120 20.1          896 11.9 
15-21 days    1,067 10.1          612 8.1 
22-30 days      742 7.0           631 8.4 
31-60 days      742 7.0         1,194 15.8 
61-90 days      125 1.2           643 8.5 
Greater than 90 days       83 0.8         1,348 17.8 
Total   10,542 100.0       7,554 100.0 
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4.3 Profile of palliative care phases 
 
The palliative care phase type describes the stage of the patient’s illness and provides a clinical indication of the level of care a patient requires. There are five palliative 
care phase types; stable, unstable, deteriorating, terminal and bereaved. The stable, unstable, deteriorating and terminal phase types can occur in any sequence and a 
patient may move back and forth between them.  
 
 
 
Table 22  Number of phases by phase type and setting 
Phase type 
Inpatient Ambulatory & community 
N % N % 
Stable                               6,797 24.4        5,193 36.7 
Unstable                             7,321 26.3        1,987 14.1 
Deteriorating                        7,634 27.4        5,421 38.4 
Terminal                             4,480 16.1        1,373 9.7 
Bereaved                             1,582 5.7           159 1.1 
All phases   27,814 100.0      14,133 100.0 
 
 
Table 23  Average phase length (in days) by phase type and setting 
Phase type Inpatient Ambulatory & community 
Stable                            7.5          23.2 
Unstable                          3.6           8.0 
Deteriorating                     5.5          16.2 
Terminal                          2.2           3.1 
Bereaved                          1.2           3.0 
Note: Phase records where phase length was greater than 90 days were considered to be atypical and are excluded from the average calculations. 
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Table 24 presents information relating to the manner in which stable phases ended. A stable phase will end if a patient moves into a different phase (phase change), is 
discharged or dies. Figure 15 and Figure 16 summarise the movement of patients out of the stable phase for the inpatient and ambulatory & community settings. This 
movement from one phase to another is referred to as phase progression. The phase progression information is derived by PCOC. The “Unknown” category has been 
included to account for situations where subsequent phase records have not been submitted to PCOC, meaning the phase progression cannot be determined. 
Similar information is presented for the unstable, deteriorating and terminal phases on the following pages. 
Table 24 How stable phases end – by setting 
Phase end reason 
Inpatient Ambulatory & community 
N % N % 
Phase change (see figures below)                   3,986  58.6 3,062  59.0 
Discharge/case closure            2,651  39.0 1,704  32.8 
Died                                151   2.2   401   7.7 
Bereavement phase end                 5   0.1     4   0.1 
Not stated/inadequately described     4   0.1    22   0.4 
Total 6,797 100.0 5,193 100.0 
 
Figure 15  Stable phase progression – inpatient setting 
 
Figure 16  Stable phase progression – ambulatory & community settings 
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Table 25 How unstable phases end – by setting 
Phase end reason 
Inpatient Ambulatory & community 
N % N % 
Phase change (see figures below)                     6,498  88.8 1,323  66.6 
Discharge/case closure              483   6.6   557  28.0 
Died                                296   4.0   101   5.1 
Bereavement phase end                14   0.2     1   0.1 
Not stated/inadequately described    30   0.4     5   0.3 
Total 7,321 100.0 1,987 100.0 
 
 
 
 
Figure 17  Unstable phase progression – inpatient setting 
 
 
Figure 18  Unstable phase progression – ambulatory & community 
settings 
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Table 26 How deteriorating phases end – by setting 
Phase end reason 
Inpatient Ambulatory & community 
N % N % 
Phase change  (see figures below)                      5,211  68.3 2,577  47.5 
Discharge/case closure            1,178  15.4 2,043  37.7 
Died                              1,185  15.5   792  14.6 
Bereavement phase end                40   0.5     2   0.0 
Not stated/inadequately described    20   0.3     7   0.1 
Total 7,634 100.0 5,421 100.0 
 
 
 
 
Figure 19  Deteriorating phase progression – inpatient setting 
 
 
Figure 20  Deteriorating phase progression – ambulatory & community 
settings 
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Table 27  How terminal phases end – by setting 
Phase end reason 
Inpatient Ambulatory & community 
N % N % 
Phase change  (see figures below)                        519  11.6   293  21.3 
Discharge/case closure               95   2.1   157  11.4 
Died                              3,720  83.0   917  66.8 
Bereavement phase end               135   3.0     2   0.1 
Not stated/inadequately described    11   0.2     4   0.3 
Total 4,480 100.0 1,373 100.0 
 
 
 
 
Figure 21  Terminal phase progression – inpatient setting 
 
 
Figure 22  Terminal phase progression – ambulatory & community 
settings 
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The Palliative Care Problem Severity Score (PCPSS) is a ‘clinician rated’ screening tool to assess the overall degree of problems within four key palliative care domains 
(pain, other symptoms, psychological/spiritual and family/carer). The ratings are: 0 = absent, 1 = mild, 3 = moderate and 4 = severe. The use of this tool provides an 
opportunity to assist in the need or urgency of intervention e.g. a score of severe in the family/carer domain could trigger a more detailed assessment by a skilled social 
worker or pastoral care worker to establish appropriate treatment or intervention. 
Tables 28 and 29 show the percentage scores for the inpatient and ambulatory and community settings respectively. 
 
Table 28  Profile of PC Problem Severity scores at beginning of phase by phase type – inpatient setting (percentages) 
Phase type Problem severity Absent Mild Moderate Severe 
Stable                            Pain                    44.0 38.5 14.1  3.5 
Other symptoms          21.7 44.0 26.2  8.1 
Psychological/spiritual 27.5 47.5 18.7  6.3 
Family/carer            36.3 40.1 17.1  6.5 
Unstable                          Pain                    25.5 29.0 30.1 15.5 
Other symptoms           9.4 26.9 40.3 23.4 
Psychological/spiritual 16.2 38.0 31.4 14.4 
Family/carer            22.4 34.6 28.6 14.5 
Deteriorating                     Pain                   36.3 33.3 21.6  8.7 
Other symptoms          13.1 30.7 36.1 20.0 
Psychological/spiritual 21.7 40.6 25.8 11.9 
Family/carer            25.3 33.9 26.4 14.5 
Terminal                          Pain                    44.9 29.7 17.0  8.4 
Other symptoms          30.2 23.7 24.0 22.1 
Psychological/spiritual 44.3 28.5 15.8 11.5 
Family/carer            16.9 28.6 29.8 24.8 
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Table 29  Profile of PC Problem Severity scores at beginning of phase by phase type – ambulatory and community settings (percentages) 
Phase type Problem severity Absent Mild Moderate Severe 
Stable                            Pain                    37.8 48.3 12.0  1.9 
Other symptoms          14.1 55.3 27.2  3.4 
Psychological/spiritual 24.0 53.2 19.2  3.6 
Family/carer            22.7 47.0 24.5  5.8 
Unstable                          Pain                    15.9 30.7 34.2 19.2 
Other symptoms           4.9 23.9 46.6 24.6 
Psychological/spiritual 12.0 35.6 35.5 16.9 
Family/carer            14.9 25.5 33.9 25.7 
Deteriorating                     Pain                   24.5 45.7 24.1  5.7 
Other symptoms           5.4 34.1 47.6 12.9 
Psychological/spiritual 15.7 45.6 30.6  8.1 
Family/carer            12.3 33.9 40.7 13.1 
Terminal                          Pain                    32.3 43.1 19.7  4.9 
Other symptoms          18.0 32.9 30.9 18.2 
Psychological/spiritual 41.6 34.7 15.9  7.8 
Family/carer            10.8 24.9 39.2 25.1 
 
 
The Symptom Assessment Scale (SAS) is a ‘patient rated’ assessment tool and reports a level of distress using a visual analogue scale from 0 = no problems to 10 = worst 
possible problems. The SAS reports on seven symptoms identified as the main cancer and palliative care problems (difficulty sleeping, appetite problems, nausea, bowel 
problems, breathing problems, fatigue and pain). It provides a clinical picture of these seven symptoms from the patients perspective e.g. a patient may rate their 
nausea at 8, hence an alert for further review. The SAS scores are grouped in tables 30 and 31 on the following pages using the same categories as the PCPSS i.e. absent 
(0), mild (1-3), moderate (4-7) and severe (8-10).  
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 Table 30  Profile of Symptom Assessment Scale scores at beginning of phase by phase type – inpatient setting (percentages) 
Phase type Symptom severity Absent Mild Moderate Severe 
Stable                            Insomnia 63.2 20.9 13.7  2.1 
Appetite problems 47.5 23.0 24.4  5.1 
Nausea 79.0 13.1  6.7  1.2 
Bowel problems 57.7 23.2 15.4  3.7 
Breathing problems 62.2 19.6 13.6  4.6 
Fatigue 22.9 22.3 42.2 12.6 
Pain 44.2 32.4 20.0  3.4 
Unstable                          Insomnia 50.4 19.7 23.2  6.8 
Appetite problems 32.8 19.7 33.5 14.0 
Nausea 63.6 15.7 15.0  5.8 
Bowel problems 44.6 22.6 23.7  9.1 
Breathing problems 51.2 19.1 19.3 10.4 
Fatigue 15.2 12.9 46.0 25.9 
Pain 28.1 24.0 32.6 15.3 
Deteriorating                     Insomnia 64.8 15.9 15.9  3.5 
Appetite problems 43.6 17.0 26.1 13.3 
Nausea 74.2 12.8  9.5  3.5 
Bowel problems 53.2 19.9 20.6  6.3 
Breathing problems 53.5 17.3 19.5  9.7 
Fatigue 21.4 10.3 38.9 29.4 
Pain 37.1 26.8 28.1  7.9 
Terminal                          Insomnia 87.1  6.3  5.2  1.4 
Appetite problems 82.6  4.3  5.4  7.8 
Nausea 91.1  4.5  3.2  1.1 
Bowel problems 78.2  9.3  8.8  3.7 
Breathing problems 61.4 13.3 15.0 10.3 
Fatigue 64.6  4.5 10.3 20.6 
Pain 54.3 20.2 20.3  5.2 
         
 Patient Outcomes in Palliative Care, Report 13 (January - June 2012) - National Report on Patient Outcomes in Palliative Care in Australia 43 
Table 31  Profile of Symptom Assessment Scale scores at beginning of phase by phase type – ambulatory and community settings (percentages) 
Phase type Symptom severity Absent Mild Moderate Severe 
Stable                            Insomnia 51.1 34.0 13.3  1.6 
Appetite problems 32.8 37.9 25.7  3.6 
Nausea 74.2 20.3  5.1  0.5 
Bowel problems 56.3 31.7 10.7  1.3 
Breathing problems 50.8 33.9 13.2  2.0 
Fatigue 10.0 33.0 48.0  9.0 
Pain 38.9 44.7 14.9  1.5 
Unstable                          Insomnia 34.8 33.1 25.7  6.4 
Appetite problems 20.0 26.4 41.5 12.2 
Nausea 54.8 23.2 16.0  6.0 
Bowel problems 40.5 33.8 20.1  5.6 
Breathing problems 43.2 29.6 22.2  5.0 
Fatigue  5.8 12.8 59.3 22.1 
Pain 17.2 30.4 36.7 15.7 
Deteriorating                     Insomnia 48.5 30.3 18.5  2.7 
Appetite problems 25.9 28.6 34.5 11.1 
Nausea 66.9 22.2  9.4  1.6 
Bowel problems 50.9 30.3 16.0  2.8 
Breathing problems 40.7 31.8 22.9  4.7 
Fatigue  7.3 14.6 55.0 23.0 
Pain 30.5 39.4 26.4  3.7 
Terminal                          Insomnia 75.9 12.3  8.9  2.8 
Appetite problems 60.2  5.6 10.8 23.4 
Nausea 86.1  9.7  3.3  0.8 
Bowel problems 69.9 18.6  9.0  2.4 
Breathing problems 49.4 22.9 20.5  7.2 
Fatigue 38.0  2.7 13.1 46.3 
Pain 43.0 35.5 18.2  3.3 
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The RUG-ADL consists of four items (bed mobility, toileting, transfers and eating) and assesses the level of functional dependence, based on what a person actually does, 
rather than what they are capable of doing. The RUG-ADL should be assessed on admission, at phase change and at episode end. The figures on the following two pages 
summarise the total RUG-ADL at the beginning of each phase for inpatients and ambulatory and community patients. The total score on the RUG-ADL ranges from a 
minimum of 4 (lowest level of functional dependency) to a maximum of 18 (highest level of functional dependency). 
The Australia-modified Karnofsky Performance Status (AKPS) is a measure of the patient’s overall performance status or ability to perform their activities of daily living. It 
is a single score between 0 and 100 assigned by a clinician based on observations of a patient’s ability to perform common tasks relating to activity, work and self-care. A 
score of 100 signifies normal physical abilities with no evidence of disease. Decreasing numbers indicate a reduced performance status. The AKPS is often used in 
assessment of prognosis and is applicable to both inpatient and community palliative care. Table 32 shows the data for the AKPS at phase start. 
AKPS & RUG-ADL can be used together to provide a profile of both patient dependency, equipment requirements, need for allied health referrals and carer 
burden/respite requirements. 
 
Table 32  Australia-modified Karnofsky Performance Status (AKPS) at phase start by setting 
AKPS  assessment 
Inpatient Ambulatory & community 
N % N % 
10 - Comatose or barely rousable    2,635     10.1      654      4.7 
20 - Totally bedfast and requiring extensive nursing care    5,324     20.4    1,350      9.7 
30 - Almost completely bedfast    3,236     12.4      884      6.4 
40 - In bed more than 50% of the time    4,486     17.2    1,620     11.7 
50 - Requires considerable assistance    4,669     17.9    3,399     24.4 
60 - Requires occasional assistance    3,251     12.4    3,130     22.5 
70 - Cares for self      882      3.4    1,801     13.0 
80 - Normal activity with effort      252      1.0      579      4.2 
90 - Able to carry on normal activity; minor signs or symptoms       64      0.2      166      1.2 
100 - Normal; no complaints; no evidence of disease        4      0.0        6      0.0 
Not stated/inadequately described    1,328      5.1      316      2.3 
Total   26,131    100.0   13,905    100.0 
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Figure 23  Total RUG-ADL at beginning of phase by phase type – inpatient setting 
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Figure 24  Total RUG-ADL at beginning of phase by phase type – ambulatory & community settings 
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Appendix A – Data scoping method 
 
The method used to determine which data is included in a PCOC report looks at the phase level records first. All phase records that end within the 6 month reporting 
period are deemed to be “in scope” and would be included in the report. The episode and patient records associated with these phases are also deemed to be “in scope” 
and hence would also be included in the report. 
 
Figure 25 below displays four examples to help visualize this process. 
 
Figure 25  Diagram of the PCOC data scoping method 
 
 
In Example 1, the patient (represented by the green line) has one episode (represented by the blue line). This episode has six phases (represented by the purple line 
segments). All six phases would be included in the report as they all end within the reporting period. Hence, the episode and patient would also be in the report. 
 
In Example 2, the patient has two episodes - the first having six phases and the second having seven phases. Looking at the phases associated with the first episode, the 
last four will be included in the report (as they end within the reporting period). The first two phases would have been included in the previous report. For the phases 
relating to the second episode, only the first three end within the reporting period, so only these would be included in the report. The following four phases would be 
included in the next report. Both of the episode records and the patient record would also be included in the report.  
 
In Example 3, the patient has one episode and five phases. Only the last three phases will be included in the report as they are the only ones ending within the reporting 
period (the first two phases would have been included in the previous report). The episode and patient records would be included in the report. 
 
In Example 4, the patient again has one episode and five phases. This time, only the first three phases will be included in the report (the last two phases will be included 
in the next report). Again, the episode and patient records would be included in the report. 
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Appendix B – X-CAS technical notes 
 
The procedure for calculating X-CAS is as follows: 
 
Step 1. Using the baseline data, calculate the average change in symptom for all patients in the same phase, having the same symptom start score. This is 
 called the expected change. 
Step 2. For each individual phase, calculate the change in symptom score (start score minus end score) 
Step 3. For each individual phase, calculate the difference between their change in symptom score (calculated in step 2) and the relevant expected change 
 (calculated in step 1).  
Step 4. Average all of the values calculated in step 3 to produce the service’s Symptom Casemix-Adjusted Score (e.g. PCAS).  
 
Example: 
Phase PCPSS Pain  
at start 
PCPSS Pain  
at end 
Step 1: Expected PCPSS Pain change 
(from Report 6 National Database) 
Step2: PCPSS Pain change 
(start score minus end score) 
Step 3: Difference 
(Step 2 minus Step 1) 
Step 4: Average of values in step 3 
Stable 0 1 -0.8 -1 -0.2  
-0.2+0.9+0.4-0.4 
4 
  = 0.175 
Stable 1 1 -0.9 0 0.9 
Unstable 3 1 1.6 2 0.4 
Deteriorating 2 1 1.4 1 -0.4 
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